Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sangamo Therapeutics Inc

0.8749
+0.01521.77%
Volume:4.82M
Turnover:4.14M
Market Cap:182.55M
PE:-1.26
High:0.9100
Open:0.8600
Low:0.8113
Close:0.8597
Loading ...

US Equity Indexes Decline After Midday Tuesday as 2024 Draws to Close

MT Newswires Live
·
01 Jan

Top Stock Movers Now: Moderna, Verisign, Dave, and More

Investopedia
·
01 Jan

Top Midday Stories: Sangamo Shares Fall After Pfizer Exits Collaboration; Dave Denies DOJ Allegations

MT Newswires Live
·
01 Jan

Sangamo Therapeutics' stock falls the most in 16 years after Pfizer ends Hemophilia pact

Dow Jones
·
01 Jan

Sangamo selloff on Pfizer decision overdone, says H.C. Wainwright

TIPRANKS
·
01 Jan

Pfizer Exit Sends Sangamo Plummeting 50%, Casting Doubt on Hemophilia Gene Therapy's Future

GuruFocus.com
·
01 Jan

Sangamo price target lowered to $3 from $7 at Jefferies

TIPRANKS
·
01 Jan

Sangamo Therapeutics Inc : Jefferies Cuts Target Price to $3 From $7

THOMSON REUTERS
·
31 Dec 2024

Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact

Investopedia
·
31 Dec 2024

SGMO Pre-Market Shares Drop 40% Over Pfizer (PFE) Deal Collapse

Insider Monkey
·
31 Dec 2024

Sangamo Therapeutics Stock Plummets 50% After Pfizer Ends Hemophilia Treatment Partnership -- Barrons.com

Dow Jones
·
31 Dec 2024

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

Benzinga
·
31 Dec 2024

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
31 Dec 2024

Sangamo's Cash on Balance Sheet Seen as 'Overhang' as Pfizer Pulls Out of Hemophilia A Therapy Study, Truist Says

MT Newswires Live
·
31 Dec 2024

Sangamo Therapeutics Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
31 Dec 2024

SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate

Zacks
·
31 Dec 2024